# Oncogenic H‐Ras Reprograms Madin‐Darby Canine Kidney (MDCK) Cell‐Derived Midbody Remnant Proteome Following Epithelial‐Mesenchymal Transition

**Authors:** Adnan Shafiq, Alin Rai, Rong Xu, Maoshan Chen, Wittaya Suwakulsiri, David W. Greening, Richard J. Simpson

PMC · DOI: 10.1002/pmic.70051 · 2025-10-01

## TL;DR

The study shows how oncogenic H-Ras changes the protein content of midbody remnants in kidney cells undergoing epithelial-mesenchymal transition.

## Contribution

The paper identifies a unique proteome signature of midbody remnants following oncogenic transformation and EMT.

## Key findings

- MBRs from mesenchymal cells show enrichment in Wnt signaling and immune checkpoint proteins like NT5E/CD73.
- Epithelial-derived MBRs are enriched in mitochondrial and plasma membrane proteins.
- MBRs have a distinct proteome compared to exosomes, including centralspindlin complex and cytokinesis factors.

## Abstract

Epithelial‐mesenchymal transition (EMT) is a fundamental, dynamic cellular process involved in embryonic development, metastasis, organ fibrosis, and tissue regeneration. To define the molecular landscape of secreted midbody remnants (MBRs) to the EMT process, a proteome analysis of MBRs released from Madin–Darby canine kidney (MDCK) cells and following oncogenic H‐Ras transformation (21D1 cells) was performed. MBRs, a new class of membranous extracellular vesicle (EV) molecularly distinct from exosomes/small EVs, were purified using sequential centrifugation/buoyant density gradient centrifugation. Proteomic profiling revealed MDCK cell‐MBRs reflect their epithelial origin (e.g., enriched CDH1, DSP, THBS1, OLCN, EPCAM proteins) and 21D1 cell‐MBRs their oncogenic and mesenchymal phenotype (e.g., HRAS, VIM, MMP14, CDH2, WNT5A, and enriched invasive and cell motility protein networks). Validation of proteome cargo revealed key protein networks associated with the EMT process in MBRs, and conserved MBR proteome across different cell types. Prominent findings were the unique expression of the immune checkpoint protein NT5E/CD73 (ecto‐5′‐nucleotidase) and ser/thr kinases LIMK1/K2 in MBRs from mesenchymal cells following their oncogenic transformation, and enrichment in Wnt signaling network proteins. These data identify the core proteome of MBRs regulated during the dynamic process of EMT and cell transformation over other EV types in context of the EMT process.

Epithelial‐to‐mesenchymal transition (EMT) is a critical cell biological process that occurs during embryonic development and cancer progression. Our study describes sequential purification of secreted midbody remnants (MBRs) and exosomes/sEVs from the in vitro cell line EMT model Madin–Darby canine kidney (MDCK) cells and MDCK cells transformed with oncogenic H‐Ras (21D1 cells): Proteomics identified the repertoire of enriched MDCK‐MBR proteins following EMT.MBRs display a proteome profile distinct from sEVs that is enriched with factors of the centralspindlin complex (KIF23.1, KIF4A, INCENP, CEP55, PLK1) and further includes components of the mitochondrial network, cytokinesis, microtubule movement, and intercellular connection.In the context of EMT, our data reveal enriched EMT pathways in MBRs including signaling receptor binding, regulation of cell differentiation, and Wnt, VEGF, and PDGF signaling. We have validated these findings in the context of Wnt signaling in other EV types.We identify several mesenchymal‐enriched networks in MBRs associated with focal adhesion, cell matrix, kinase activity, and cell shape/organization, while epithelial‐derived MBRs show enriched networks predominantly associated with mitochondrial (processing/transport), midbody, and plasma membrane annotation.Our study sheds light on the proteome architecture of MBRs following oncogenic H‐Ras‐induced EMT in cell transformation: collectively, our data informs ongoing efforts to delineate oncogenic drivers of cancer initiation, progression, and metastasis.

Epithelial‐to‐mesenchymal transition (EMT) is a critical cell biological process that occurs during embryonic development and cancer progression. Our study describes sequential purification of secreted midbody remnants (MBRs) and exosomes/sEVs from the in vitro cell line EMT model Madin–Darby canine kidney (MDCK) cells and MDCK cells transformed with oncogenic H‐Ras (21D1 cells): Proteomics identified the repertoire of enriched MDCK‐MBR proteins following EMT.

MBRs display a proteome profile distinct from sEVs that is enriched with factors of the centralspindlin complex (KIF23.1, KIF4A, INCENP, CEP55, PLK1) and further includes components of the mitochondrial network, cytokinesis, microtubule movement, and intercellular connection.

In the context of EMT, our data reveal enriched EMT pathways in MBRs including signaling receptor binding, regulation of cell differentiation, and Wnt, VEGF, and PDGF signaling. We have validated these findings in the context of Wnt signaling in other EV types.

We identify several mesenchymal‐enriched networks in MBRs associated with focal adhesion, cell matrix, kinase activity, and cell shape/organization, while epithelial‐derived MBRs show enriched networks predominantly associated with mitochondrial (processing/transport), midbody, and plasma membrane annotation.

Our study sheds light on the proteome architecture of MBRs following oncogenic H‐Ras‐induced EMT in cell transformation: collectively, our data informs ongoing efforts to delineate oncogenic drivers of cancer initiation, progression, and metastasis.

## Linked entities

- **Genes:** HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265], CDH1 (cadherin 1) [NCBI Gene 999], DSP (desmoplakin) [NCBI Gene 1832], THBS1 (thrombospondin 1) [NCBI Gene 7057], EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072], VIM (vimentin) [NCBI Gene 7431], MMP14 (matrix metallopeptidase 14) [NCBI Gene 4323], CDH2 (cadherin 2) [NCBI Gene 1000], WNT5A (Wnt family member 5A) [NCBI Gene 7474], NT5E (5'-nucleotidase ecto) [NCBI Gene 4907], LIMK1 (LIM domain kinase 1) [NCBI Gene 3984], LIMK2 (LIM domain kinase 2) [NCBI Gene 3985], KIF23_1 (Kinesin-like protein kif23) [NCBI Gene 24591110], KIF4A (kinesin family member 4A) [NCBI Gene 24137], INCENP (inner centromere protein) [NCBI Gene 3619], CEP55 (centrosomal protein 55) [NCBI Gene 55165], PLK1 (polo like kinase 1) [NCBI Gene 5347]
- **Proteins:** CDH1 (cadherin 1), DSP (desmoplakin), THBS1 (thrombospondin 1), EPCAM (epithelial cell adhesion molecule), VIM (vimentin), MMP14 (matrix metallopeptidase 14), CDH2 (cadherin 2), WNT5A (Wnt family member 5A), KIF23_1 (Kinesin-like protein kif23), KIF4A (kinesin family member 4A), INCENP (inner centromere protein), CEP55 (centrosomal protein 55), PLK1 (polo like kinase 1)

## Full-text entities

- **Genes:** WNT5A (Wnt family member 5A) [NCBI Gene 484721], INCENP (inner centromere protein) [NCBI Gene 483790], PLK1 (polo like kinase 1) [NCBI Gene 489971], CDH1 (cadherin 1) [NCBI Gene 442858] {aka Cadherin-1, Uvomorulin}, CDH2 (cadherin 2) [NCBI Gene 480169] {aka NCAD}, CEP55 [NCBI Gene 608315], VEGFA (vascular endothelial growth factor A) [NCBI Gene 403802] {aka VEGF}, HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 403735] {aka H-RAS}, MMP14 (matrix metallopeptidase 14) [NCBI Gene 403823] {aka MMP-14}, DSP (desmoplakin) [NCBI Gene 488207], EPCAM (epithelial cell adhesion molecule) [NCBI Gene 481360] {aka TACSTD1}, KIF4A (kinesin family member 4A) [NCBI Gene 491941], VIM (vimentin) [NCBI Gene 477991], NT5E (5'-nucleotidase ecto) [NCBI Gene 474984], THBS1 (thrombospondin 1) [NCBI Gene 487486]
- **Diseases:** metastasis (MESH:D009362), cancer (MESH:D009369), fibrosis (MESH:D005355)
- **Cell lines:** MDCK — Canis lupus familiaris (Dog), Spontaneously immortalized cell line (CVCL_0422), 21D1 — Canis lupus familiaris (Dog), Canine osteosarcoma, Cancer cell line (CVCL_S349)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976838/full.md

---
Source: https://tomesphere.com/paper/PMC12976838